ARDELYX, INC. Increase (Decrease) in Other Operating Assets
ARDELYX, INC. (ARDX) reported Increase (Decrease) in Other Operating Assets of -$334.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2014-11-07
- ARDELYX, INC. increase (decrease) in other operating assets for the quarter ending 2014-09-30 was $11.00K.
- ARDELYX, INC. increase (decrease) in other operating assets for the quarter ending 2013-09-30 was -$202.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2014-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$334.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$345.00K 10-Q · filed 2014-08-08 | ||
| 2013-09-30 | -$202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $529.00K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $731.00K 10-Q · filed 2014-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |